Strong Support
descriptive
Analysis v2
History

Taking 0.15 mg of nonivamide daily in a milk shake for 12 weeks does not change the levels of hormones in the blood that signal fullness, such as GLP-1, PYY, or ghrelin, in adults who are moderately...

60
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

A daily dose of 0.15 mg nonivamide in a milk shake activates a gut sensor called TRPV1, which makes gut cells release more serotonin into the blood — but this doesn’t change the levels of hunger or fullness hormones like GLP-1, PYY, or ghrelin, as shown in 10.1002/mnfr.201600731.

Most probable mechanism

In Simple Terms

Taking a tiny amount of nonivamide in a milk shake every day for 12 weeks activates a specific sensor in the gut called TRPV1, which causes gut cells to release more serotonin into the blood — but this doesn't change the levels of hormones like GLP-1, PYY, or ghrelin that signal fullness, as shown in 10.1002/mnfr.201600731.

Causal chain
1

Nonivamide binds to and activates TRPV1 receptors on enterochromaffin cells in the intestinal epithelium, triggering intracellular calcium signaling — supported by 10.1002/mnfr.201600731, which relies on established pharmacology of nonivamide as a TRPV1 agonist.

Indirect evidence only
which leads to
2

TRPV1 activation induces calcium influx into enterochromaffin cells, leading to exocytosis of serotonin-containing vesicles — supported by 10.1002/mnfr.201600731, which observed increased postprandial plasma serotonin levels following nonivamide intake.

Supported by evidence
which leads to
3

Released serotonin enters systemic circulation, elevating plasma serotonin concentrations — directly measured in 10.1002/mnfr.201600731, which found significant increases in postprandial serotonin without changes in GLP-1, PYY, or ghrelin.

Verified by multiple studies
which leads to
4

Elevated peripheral serotonin does not alter fasting or postprandial concentrations of GLP-1, PYY, or ghrelin — directly confirmed by 10.1002/mnfr.201600731, which measured these satiety hormones at multiple time points and found no statistically significant changes.

Verified by multiple studies

Evidence from Studies

Supporting (1)

60

Community contributions welcome

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Science Topic

Does 0.15 mg of nonivamide in a milk shake affect satiety hormones in overweight adults?

Supported
Nonivamide & Satiety

We analyzed one assertion about whether 0.15 mg of nonivamide in a milk shake affects satiety hormones in overweight adults, and found no change in blood levels of GLP-1, PYY, or ghrelin after 12 weeks of daily use. This single observation is supported by 60.0 reports, with no studies contradicting it. Nonivamide is a compound related to capsaicin, often found in chili peppers, and is sometimes added to foods for mild heat or potential metabolic effects. Satiety hormones like GLP-1 and PYY help signal fullness after eating, while ghrelin triggers hunger. The evidence we’ve reviewed suggests that at this very low dose — 0.15 mg — taken daily in a milk shake, these hormones do not appear to shift in adults who are moderately overweight over a 12-week period. It’s important to note that this conclusion is based on only one assertion, even though it is supported by 60.0 reports. We don’t know how those reports were gathered, whether they were controlled trials, or if other factors like diet or activity levels were accounted for. There is no evidence here showing that nonivamide increases fullness, reduces appetite, or changes weight — only that these specific hormones stayed the same. What we’ve found so far does not suggest that this small amount of nonivamide in a milk shake has a measurable effect on the body’s signals for hunger or fullness in this group. But with only one assertion analyzed, we can’t say whether higher doses, longer use, or different forms might behave differently. If you’re trying to feel fuller longer, this specific dose and delivery method doesn’t appear to influence the key hormones involved — at least not based on what we’ve reviewed so far.

0 items of evidenceView full answer